Literature DB >> 24372670

Electrocardiography at diagnosis and close to the time of death in pulmonary arterial hypertension.

Adriano R Tonelli1, Manfred Baumgartner, Laith Alkukhun, Omar A Minai, Raed A Dweik.   

Abstract

BACKGROUND: Scarce information exits on the electrocardiographic (ECG) characteristics of pulmonary arterial hypertension (PAH) patients close to their death and whether observed abnormalities progress from the time of PAH diagnosis.
METHODS: We analyzed the characteristics of the ECG performed at initial diagnosis, during the course of the disease and close to the time of death on consecutive PAH patients followed at our institution between June 2008 and December 2010.
RESULTS: We included 50 patients with PAH (76% women) with mean (SD) age of 58 (14) years. Median heart rate (83 vs 89 bpm, P = 0.001), PR interval (167 vs 176 ms, P = 0.03), QRS duration (88 vs 90 ms, P = 0.02), R/S ratio in lead V1 (1 vs 2, P = 0.01), and QTc duration (431 vs 444 ms, P = 0.02) significantly increased from the initial to the last ECG. In addition, the frontal QRS axis rotated to the right (97 vs 112 degrees, P = 0.003) and we more commonly observed right bundle branch block (5% vs 8%, P = 0.03) and negative T waves in inferior leads (31% vs 60%, P = 0.004). No patient had normal ECG at the time of death.
CONCLUSIONS: Significant changes progressively occur in a variety of ECG parameters between the time of the initial PAH diagnosis and close to death. ©2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  electrocardiography; outcome assessment; pulmonary hypertension

Mesh:

Year:  2013        PMID: 24372670      PMCID: PMC4004655          DOI: 10.1111/anec.12125

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  31 in total

1.  Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension.

Authors:  Joern Tongers; Ben Schwerdtfeger; Gunnar Klein; Tibor Kempf; Arnd Schaefer; Julia-Marie Knapp; Michael Niehaus; Thomas Korte; Marius M Hoeper
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

Review 2.  Diagnosis and assessment of pulmonary arterial hypertension.

Authors:  David B Badesch; Hunter C Champion; Miguel Angel Gomez Sanchez; Marius M Hoeper; James E Loyd; Alessandra Manes; Michael McGoon; Robert Naeije; Horst Olschewski; Ronald J Oudiz; Adam Torbicki
Journal:  J Am Coll Cardiol       Date:  2009-06-30       Impact factor: 24.094

3.  Guidelines for the diagnosis and treatment of pulmonary hypertension.

Authors:  N Galiè; M M Hoeper; M Humbert; A Torbicki; J-L Vachiery; J A Barbera; M Beghetti; P Corris; S Gaine; J S Gibbs; M A Gomez-Sanchez; G Jondeau; W Klepetko; C Opitz; A Peacock; L Rubin; M Zellweger; G Simonneau
Journal:  Eur Respir J       Date:  2009-09-12       Impact factor: 16.671

4.  Heart rate-corrected QT interval and QT dispersion in patients with pulmonary hypertension.

Authors:  Zhang Hong-liang; Luo Qin; Liu Zhi-hong; Zhao Zhi-hui; Xiong Chang-ming; Ni Xin-hai; He Jian-guo; Wei Ying-jie; Zhang Shu
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).

Authors:  Raymond L Benza; Dave P Miller; Mardi Gomberg-Maitland; Robert P Frantz; Aimee J Foreman; Christopher S Coffey; Adaani Frost; Robyn J Barst; David B Badesch; C Gregory Elliott; Theodore G Liou; Michael D McGoon
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

6.  Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaïci; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Vincent Cottin; Bruno Degano; Xavier Jaïs; David Montani; Rogério Souza; Gérald Simonneau
Journal:  Circulation       Date:  2010-06-28       Impact factor: 29.690

7.  QTc prolongation is associated with impaired right ventricular function and predicts mortality in pulmonary hypertension.

Authors:  Jonathan D Rich; Thenappan Thenappan; Benjamin Freed; Amit R Patel; Ronald A Thisted; Rory Childers; Stephen L Archer
Journal:  Int J Cardiol       Date:  2012-03-27       Impact factor: 4.164

8.  Prolonged QRS duration: a new predictor of adverse outcome in idiopathic pulmonary arterial hypertension.

Authors:  Pei-Yu Sun; Xin Jiang; Mardi Gomberg-Maitland; Qin-Hua Zhao; Jing He; Ping Yuan; Rui Zhang; Zhi-Cheng Jing
Journal:  Chest       Date:  2011-07-21       Impact factor: 9.410

9.  Causes and circumstances of death in pulmonary arterial hypertension.

Authors:  Adriano R Tonelli; Vineesha Arelli; Omar A Minai; Jennie Newman; Nancy Bair; Gustavo A Heresi; Raed A Dweik
Journal:  Am J Respir Crit Care Med       Date:  2013-08-01       Impact factor: 21.405

Review 10.  ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association.

Authors:  Vallerie V McLaughlin; Stephen L Archer; David B Badesch; Robyn J Barst; Harrison W Farber; Jonathan R Lindner; Michael A Mathier; Michael D McGoon; Myung H Park; Robert S Rosenson; Lewis J Rubin; Victor F Tapson; John Varga; Robert A Harrington; Jeffrey L Anderson; Eric R Bates; Charles R Bridges; Mark J Eisenberg; Victor A Ferrari; Cindy L Grines; Mark A Hlatky; Alice K Jacobs; Sanjay Kaul; Robert C Lichtenberg; Jonathan R Lindner; David J Moliterno; Debabrata Mukherjee; Gerald M Pohost; Robert S Rosenson; Richard S Schofield; Samuel J Shubrooks; James H Stein; Cynthia M Tracy; Howard H Weitz; Deborah J Wesley
Journal:  Circulation       Date:  2009-03-30       Impact factor: 29.690

View more
  13 in total

1.  Severity of arterial and chronic thromboembolic pulmonary hypertension is associated with impairment of heart rate turbulence.

Authors:  Piotr Bienias; Maciej Kostrubiec; Zuzanna Rymarczyk; Dariusz Korczak; Michał Ciurzyński; Marcin Kurzyna; Adam Torbicki; Anna Fijałkowska; Piotr Pruszczyk
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-05       Impact factor: 1.468

2.  Non-invasive screening for pulmonary hypertension in idiopathic pulmonary fibrosis.

Authors:  Laith Alkukhun; Xiao-Feng Wang; Mostafa K Ahmed; Manfred Baumgartner; Marie M Budev; Raed A Dweik; Adriano R Tonelli
Journal:  Respir Med       Date:  2016-06-02       Impact factor: 3.415

3.  Use of ECG and Other Simple Non-Invasive Tools to Assess Pulmonary Hypertension.

Authors:  Gabor Kovacs; Alexander Avian; Vasile Foris; Maria Tscherner; Xhylsime Kqiku; Philipp Douschan; Gerhard Bachmaier; Andrea Olschewski; Marco Matucci-Cerinic; Horst Olschewski
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

4.  ECG Markers of Hemodynamic Improvement in Patients with Pulmonary Hypertension.

Authors:  Marcin Waligóra; Anna Tyrka; Piotr Podolec; Grzegorz Kopeć
Journal:  Biomed Res Int       Date:  2018-04-10       Impact factor: 3.411

5.  Comparison of Mobile Application-Based ECG Consultation by Collective Intelligence and ECG Interpretation by Conventional System in a Tertiary-Level Hospital.

Authors:  You Mi Hwang; Ji Hyun Kim; Yoo Ri Kim
Journal:  Korean Circ J       Date:  2021-04       Impact factor: 3.243

6.  Extended Precordial T Wave Inversions Are Associated with Right Ventricular Enlargement and Poor Prognosis in Pulmonary Hypertension.

Authors:  Marcin Waligóra; Matylda Gliniak; Jan Bylica; Paweł Pasieka; Patrycja Łączak; Piotr Podolec; Grzegorz Kopeć
Journal:  J Clin Med       Date:  2021-05-16       Impact factor: 4.241

7.  Change in R wave in lead V1 predicts survival of patients with pulmonary arterial hypertension.

Authors:  Shinji Sato; Aiko Ogawa; Hiromi Matsubara
Journal:  Pulm Circ       Date:  2018-04-25       Impact factor: 3.017

8.  Automated and Interpretable Patient ECG Profiles for Disease Detection, Tracking, and Discovery.

Authors:  Geoffrey H Tison; Jeffrey Zhang; Francesca N Delling; Rahul C Deo
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-09-05

9.  Assessment of electrocardiographic markers of acute and long-term hemodynamic improvement in patients with pulmonary hypertension.

Authors:  Michał Piłka; Szymon Darocha; Marta Banaszkiewicz; Maria Wieteska-Miłek; Małgorzata Mańczak; Rafał Mańczak; Piotr Kędzierski; Michał Florczyk; Anna Dobosiewicz; Adam Torbicki; Marcin Kurzyna
Journal:  Ann Noninvasive Electrocardiol       Date:  2020-04-26       Impact factor: 1.468

Review 10.  Chronic Thromboembolic Pulmonary Hypertension - What Have We Learned From Large Animal Models.

Authors:  Kelly Stam; Sebastian Clauss; Yannick J H J Taverne; Daphne Merkus
Journal:  Front Cardiovasc Med       Date:  2021-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.